Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 1
Coronavirus – Letters
COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies
Nir Eyala Center for Population-Level Bioethics and Department of Philosophy, Rutgers University, New Brunswick, NJ, USA;b Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, USACorrespondence[email protected]
https://orcid.org/0000-0003-1056-6609View further author information
https://orcid.org/0000-0003-1056-6609View further author information, Arthur Caplanc Division of Medical Ethics, Grossman School of Medicine, New York University Langone, New York, NY, USAhttps://orcid.org/0000-0002-4061-8011View further author information
https://orcid.org/0000-0002-4061-8011View further author information & 